The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Patients with late-onset rheumatoid arthritis experienced greater functional impairment over 5 years, compared against those with younger-onset disease.

Cancer survivors’ use of medical equipment has increased in recent years, and this equipment has the highest proportion of OOP costs, data suggest.

Intermittent fasting may benefit antioxidant and inflammatory markers in postmenopausal women with rheumatoid arthritis.

SGLT-2 inhibitors canagliflozin, empagliflozin, and dapagliflozin showed overall comparable effectiveness on cardiovascular outcomes in T2D.

Pediatric obesity was associated with a higher prevalence of iron deficiency but not a higher prevalence of iron deficiency anemia.

Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

The FDA has issued a safety communication regarding the potential for missed alerts with diabetes devices due to software or hardware changes.

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.

Higher low-carbohydrate diet (LCD) scores, characterized by reduced carbohydrate intake and increased protein consumption, are associated with a lower likelihood of rheumatoid arthritis (RA) among ...